Clinical trial
Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
NCT00392678 is registered in ClinicalTrials.gov with Joslin Diabetes Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
- Lead sponsor
- Joslin Diabetes Center
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- October 31, 2006
- Completion date
- December 31, 2010
- Enrollment
- 277 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes